Tülin Özkan
Impact in
-
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
-
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
-
- Retinoids in leukemia and cellular processes 3
- Histone Deacetylase Inhibitors Research 3
- Hematology 17
- Chronic Myeloid Leukemia Treatments 11
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Asuman Sunguroğlu (39 shared papers)Yalda Hekmatshoar (18 shared papers)Arzu Zeynep Karabay (12 shared papers)Fügen Aktan (7 shared papers)Sena Aydos (8 shared papers)Yalda Rahbar Saadat (4 shared papers)Bahram Pourghassem Gargari (1 shared paper)Hakan Göker (3 shared papers)
In The Last Decade
Tülin Özkan
45 papers receiving 400 citations
Peers
Comparison fields: 5 of 77
- Genetics 56
- Hematology 55
- Molecular Biology 212
- Pharmacology 25
- Cancer Research 41
Countries citing papers authored by Tülin Özkan
This map shows the geographic impact of Tülin Özkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tülin Özkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tülin Özkan more than expected).
Fields of papers citing papers by Tülin Özkan
This network shows the impact of papers produced by Tülin Özkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tülin Özkan. The network helps show where Tülin Özkan may publish in the future.
Co-authors
The 25 scholars most cited alongside Tülin Özkan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 42 | |
| 2 | 2019 | 36 | |
| 3 | 2023 | 31 | |
| 4 | 2011 | 31 | |
| 5 | 2021 | 21 | |
| 6 | 2014 | 21 | |
| 7 | 2016 | 20 | |
| 8 | 2013 | 15 | |
| 9 | 2021 | 14 | |
| 10 | 2018 | 14 | |
| 11 | 2018 | 14 | |
| 12 | 2021 | 12 | |
| 13 | 2014 | 11 | |
| 14 | 2018 | 11 | |
| 15 | 2017 | 10 | |
| 16 | 2017 | 9 | |
| 17 | 2013 | 9 | |
| 18 | 2015 | 8 | |
| 19 | 2018 | 8 | |
| 20 | 2022 | 8 |
About Tülin Özkan
Tülin Özkan is a scholar working on Molecular Biology, Hematology, Organic Chemistry, Genetics and Complementary and alternative medicine, having authored 47 papers that have together received 408 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (7 papers), Quinazolinone synthesis and applications (6 papers), Synthesis and biological activity (5 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers), Multiple Myeloma Research and Treatments (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Genetics (56 citations), Hematology (55 citations), Molecular Biology (212 citations), Pharmacology (25 citations) and Cancer Research (41 citations). Tülin Özkan has collaborated with scholars based in Türkiye, Iran and Czechia. Frequent co-authors include Asuman Sunguroğlu, Yalda Hekmatshoar, Arzu Zeynep Karabay, Fügen Aktan, Sena Aydos, Yalda Rahbar Saadat, Bahram Pourghassem Gargari, Hakan Göker, Nuray Varol and Ziba Nariman‐Saleh‐Fam. Their work appears in journals such as Planta Medica, Blood, Molecular Biology Reports, Archives of Pharmacal Research and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.